Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review

Por Ellis, P.M., Coakley, N., Feld, R., Kuruvilla, S., Ung, Y.C.
Publicado no Curr Oncol (2015)

The 4th Annual Ontario Thoracic Cancer Conference at Niagara-on-the-Lake

Por Ung, Y.C., Yu, E., Malthaner, R., Burkes, R., Ellis, P., Goss, G., Solow, H., Irvine, S., Laffan, S.
Publicado em 2009

Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer

Por Falkson, C.B., Vella, E.T., Yu, E., El-Mallah, M., Mackenzie, R., Ellis, P.M., Ung, Y.C.
Publicado no Curr Oncol (2017)

Developing a methodology for three-dimensional correlation of PET–CT images and whole-mount histopathology in non-small-cell lung cancer

Por Dahele, M., Hwang, D., Peressotti, C., Sun, L., Kusano, M., Okhai, S., Darling, G., Yaffe, M., Caldwell, C., Mah, K., Hornby, J., Ehrlich, L., Raphael, S., Tsao, M., Behzadi, A., Weigensberg, C., Ung, Y.C.
Publicado em 2008